Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
688710.SS
HOLDShanghai InnoStar Bio-tech Co., Ltd. · Healthcare · China · $1.3B · Avg Vol: $31M/d
COMPANY DESCRIPTION
Shanghai InnoStar Bio-tech Co., Ltd. is a contract research organization (CRO) providing comprehensive preclinical evaluation services, including safety assessment, pharmacokinetics, and early-stage drug efficacy studies. The company's competitive moat is anchored by its state-of-the-art GLP-compliant facilities and a strong track record of successful IND filings with both the NMPA and US FDA. It is a trusted partner for innovative biopharmaceutical developers globally.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 127.1M | 152.9M | 168.1M | 119.5M | -2.0% | 119.6M |
| EPS | 0.21 | 0.27 | 0.19 | -0.03 | -5.1% | -0.03 |
| Shares | 105.7M | 105.7M | 141.0M | 141.0M | +33.3% | 141.0M |
| Debt | 36.3M | 36.3M | 34.0M | 17.0M | -22.3% | 19.2M |
| Equity | 207.3M | 238.3M | 352.3M | 342.2M | 18.2% | — |
| Op CF | 41.0M | 24.8M | -14.2M | 14.9M | -28.6% | 36.7M |
| Inv CF | -20.6M | -36.8M | -51.7M | -18.0M | — | — |
| Fin CF | 70.2M | -2.1M | 87.9M | -9.2M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688710.SS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 688710.SS | Shanghai InnoStar Bio-tech Co., Ltd.(you) | $1.3B | 62 | HOLD |
| 300357.SZ | Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | $1.6B | 61 | HOLD |
| 600713.SS | Nanjing Pharmaceutical Group Company Limited | $977M | 77 | BUY |
| 600771.SS | GuangYuYuan Chinese Herbal Medicine Co., Ltd. | $916M | 48 | HOLD |
| 300181.SZ | Zhejiang Jolly Pharmaceutical Co.,LTD | $1.3B | 85 | STRONG BUY |
| 002019.SZ | Yifan Pharmaceutical Co., Ltd. | $1.7B | 38 | HOLD |
| 000411.SZ | Zhejiang Int'l Group Co.,Ltd. | $749M | 83 | STRONG BUY |
| 301507.SZ | Hangzhou Minsheng Healthcare Co., Ltd. | $633M | 44 | HOLD |
| 002422.SZ | Sichuan Kelun Pharmaceutical Co., Ltd. | $8.3B | 66 | BUY |
| 600666.SS | Aurora Optoelectronics Co.,Ltd. | $1.7B | 25 | SELL |
Peer medians: ROE 4.7% · P/E 28.4x · Gross margin 52.5%